Your browser doesn't support javascript.
loading
Favorable COVID-19 course despite significant comorbidities in a ruxolitinib-treated patient with primary myelofibrosis.
Koschmieder, Steffen; Jost, Edgar; Cornelissen, Christian; Müller, Tobias; Schulze-Hagen, Maximilian; Bickenbach, Johannes; Marx, Gernot; Kleines, Michael; Marx, Nikolaus; Brümmendorf, Tim H; Dreher, Michael.
Afiliação
  • Koschmieder S; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.
  • Jost E; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.
  • Cornelissen C; Department of Pneumology and Intensive Care Medicine, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.
  • Müller T; Department of Pneumology and Intensive Care Medicine, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.
  • Schulze-Hagen M; Department of Diagnostic and Interventional Radiology, RWTH Aachen University, Aachen, Germany.
  • Bickenbach J; Department of Intensive Care and Intermediate Care, RWTH Aachen University, Aachen, Germany.
  • Marx G; Department of Intensive Care and Intermediate Care, RWTH Aachen University, Aachen, Germany.
  • Kleines M; Labordiagnostisches Zentrum &, Department of Medical Microbiology, RWTH Aachen University, Aachen, Germany.
  • Marx N; Clinic for Cardiology, Angiology and Internal Intensive Medicine, Medical Clinic I, RWTH Aachen University, Aachen, Germany.
  • Brümmendorf TH; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.
  • Dreher M; Department of Pneumology and Intensive Care Medicine, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.
Eur J Haematol ; 105(5): 655-658, 2020 Nov.
Article em En | MEDLINE | ID: mdl-32593209

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Pirazóis / Mielofibrose Primária / Inibidores de Janus Quinases / COVID-19 Limite: Humans / Male / Middle aged Idioma: En Revista: Eur J Haematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Pirazóis / Mielofibrose Primária / Inibidores de Janus Quinases / COVID-19 Limite: Humans / Male / Middle aged Idioma: En Revista: Eur J Haematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha